The supply of Blood Glucose & Ketone Monitoring Systems for Point of Care Testing

CPV: Blood analysers · Blood-testing reagents · Reagent strips

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Goods

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

3 Aug 2023, 08:56 BST

Last source update

3 Aug 2023, 08:56 BST

Authority reference

WPR-5514

FTS notice number

2023/S 000-022538

Classification (CPV)

Blood analysersBlood-testing reagentsReagent strips

Delivery area

South West (UKK15)

Official registry OCID

ocds-h6vhtk-03ec9f Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

Royal United Hospitals Bath NHSFT (RUH) intends to award a contract under Regulation 32(2)(b)(ii), to Abbott Laboratories Limited, in respect of Blood Glucose Monitoring Systems for Point of Care Testing, for a period of twenty one months. This is to maintain continuation of service delivery and aligns the contract end date for this requirement to the same as North Bristol NHS Trust and University Hospitals Bristol and Weston NHS Foundation Trust, while a collaborative requirement is re-tendered as a South 3 collaborative contract, to ensure greater efficiency when procuring services. Abbott Laboratories Limited is the incumbent supplier and the new contract will ensure that the current service is maintained until the re-tender is complete, without risk to patient care or the accumulation of cost and resource pressures. To award another supplier a temporary arrangement of this nature may result in the following:<br/>Trust Turnaround Times and Patient Care: Variations in turnaround while new systems are set up and training of clinical staff is is undertaken. Currently procedures are established and consistent. Risking this could lead to increased Turnaround and delays to diagnosis, and in turn treatment, of patients within the Trust.<br/>IT and Report Transcription: The reporting and interpretation of results is an established process, and staff are familiar with the current processes. <br/>IT and Documentation: Changing provider will result in additional IT resource and system/document updates that will add to the department’s ongoing quality work.<br/>RUH has reviewed the factors described and considers that for the technical reasons listed, awarding Abbott Laboratories Limited is the only reasonable solution as it mitigates the risk of a detrimental effect on the service and the accumulation of preventable cost and resource pressures until the re-tender of the collaborative contract across the Trusts. RUH will observe a 10 day standstill from the date of this notice before entering into a contract with Abbott Laboratories Limited.

• Abbott Laboratories LimitedAwarded supplier00329102 Abbott House, Vanwall Road Vanwall Business Park Maidenhead, Maidenhead, South West, SL6 4XE

No document links were published on the notice.